Skip to main content
Premium Trial:

Request an Annual Quote

InforMax Launches New Research Architecture, Forms Viaken Alliance

Premium

R

OCKVILLE, Md.--InforMax has released new enterprise bioinformatics software architecture for integrated genomics analysis called High-Throughput Research. InforMax said HTR will accelerate drug discovery through target optimization. In addition, the company has relaunched its enterprise software product suite, formerly known as Software Solution for Bio-Medicine, as GenoMax. It has also released VectorNTI Dynamic License Server version 1.1, a client-server application that manages concurrent user licenses for VectorNTI. DLS version 1.1, as it is called, is available at http://www.informaxinc.com/free/vnti_dis.html.

As part of the HTR environment, the company will release a series of products under the GenoMax product family name during the next year. This will include modules for gene expression, SNP, and protein-protein interaction analysis. In the second quarter, GenoMax 3.0, supporting EST clustering, genome viewing, and 3-D structure prediction, will be unveiled.

In other news, the company entered into an alliance with Viaken Systems. Viaken, which hosts third party research informatics application solutions and e-commerce services at its data center for delivery over the internet, will offer InforMax’s GenoMax and Vector NTI products as hosted applications. Alex Titomirov, president and CEO of InforMax, said that Viaken’s ASP model would offer customers "an additional channel to access our bioinformatics software, providing ease-of-use and dedicated servers in a highly secure environment."

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.